A 30-day preclinical safety evaluation study of recombinant human follicle-stimulating hormone in female rhesus monkeys.

about

A 30-day preclinical safety evaluation study of recombinant human follicle-stimulating hormone in female rhesus monkeys.

Item

http://www.wikidata.org/entity/Q51492942

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

A 30-day preclinical safety ev ...... mone in female rhesus monkeys.

@en

A 30-day preclinical safety ev ...... mone in female rhesus monkeys.

@nl

type

Item

label

A 30-day preclinical safety ev ...... mone in female rhesus monkeys.

@en

A 30-day preclinical safety ev ...... mone in female rhesus monkeys.

@nl

prefLabel

A 30-day preclinical safety ev ...... mone in female rhesus monkeys.

@en

A 30-day preclinical safety ev ...... mone in female rhesus monkeys.

@nl

P1476

A 30-day preclinical safety ev ...... mone in female rhesus monkeys.

@en

P2093

Changxiao Liu

http://www.w3.org/2001/XMLSchema#string

Longsheng Zhang

http://www.w3.org/2001/XMLSchema#string

Ming Li

http://www.w3.org/2001/XMLSchema#string

Yongming Cai

http://www.w3.org/2001/XMLSchema#string

Zhengmin Chen

http://www.w3.org/2001/XMLSchema#string

Zongpeng Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Induction of ovulation in women undergoing assisted reproductive techniques: recombinant human FSH (follitropin alpha) versus highly purified urinary FSH (urofollitropin HP).

Historical perspectives in gonadotrophin therapy.

Human follicle-stimulating hormone produced by recombinant DNA technology: a review for clinicians.

Advances in recombinant DNA technology: corifollitropin alfa, a hybrid molecule with sustained follicle-stimulating activity and reduced injection frequency.

Developments in human recombinant follicle stimulating hormone technology: are we going in the right direction?

Molecular biology and biochemistry of human recombinant follicle stimulating hormone (Puregon).

Comparative in vitro and in vivo studies on the biological characteristics of recombinant human follicle-stimulating hormone.

Clinical experience with recombinant follicle-stimulating hormone (FSH) and urinary FSH: a retrospective case- controlled analysis.

Comparison of the efficacy and safety of a highly purified human follicle-stimulating hormone (Bravelle) and recombinant follitropin-beta for in vitro fertilization: a prospective, randomized study.

Effect of highly purified urinary follicle-stimulating hormone on oocyte and embryo quality.

P304

153-161

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1091581810390823

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21402952

http://www.w3.org/2001/XMLSchema#string